NFKB1 and COVID-19: In contrast to extracellular Hsp70, intracellular Hsp70 has mostly anti-inflammatory properties by blocking NF-κB activation, a desirable effect for both AIBDs and COVID-19 (i.e., cytokine storm) (34).